Lung Cancer Rx

Neoadjuvant Therapy for Early-Stage Lung Cancer: Where Do Things Stand, and What’s Next?

29 min · 1. touko 2026
jakson Neoadjuvant Therapy for Early-Stage Lung Cancer: Where Do Things Stand, and What’s Next? kansikuva

Kuvaus

Given recent advances, where do things stand for neoadjuvant therapy in patients with NSCLC? The panel discusses current considerations and what important questions may soon be answered. Patrick Forde MBBCh, PhD, a thoracic medical oncologist at Johns Hopkins University in Baltimore, Maryland, and professor of immuno-oncology at Trinity College Dublin discusses current multidisciplinary approaches to perioperative care in NSCLC with Eric K. Singhi, MD, a thoracic oncologist in Houston, and Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O’Neal Cancer Center.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Lung Cancer Rx-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

12 jaksot